Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing.

Eva Rohde; Karin Pachler; Mario Gimona

doi:10.1016/j.jcyt.2018.12.006

Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing.

Eva Rohde^* (First author), Karin Pachler (Co-author), Mario Gimona (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

148 Citations (Web of Science)

Original language	English
Pages (from-to)	581-592
Journal	CYTOTHERAPY
Volume	21
Issue number	6
DOIs	https://doi.org/10.1016/j.jcyt.2018.12.006
Publication status	Published - 2019

Keywords

INCLUDING STEM-CELLS
A METHOD
EXOSOMES
MICRORNAS
GROWTH
ANGIOGENESIS
INHIBIT
PROGENY
EUROPE
US

Access to Document

10.1016/j.jcyt.2018.12.006

Cite this

@article{5d7d23dd4b5d4cd99e624a5ce477dfe9,

title = "Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing.",

keywords = "INCLUDING STEM-CELLS, A METHOD, EXOSOMES, MICRORNAS, GROWTH, ANGIOGENESIS, INHIBIT, PROGENY, EUROPE, US",

author = "Eva Rohde and Karin Pachler and Mario Gimona",

note = "all: Paracelsus Med Univ, GMP Lab, SCI TReCS, Salz; Paracelsus Med Univ, Dept Transfus Med, Salzburg, Austria; Paracelsus Med Univ, Res Program Nanovesicular Therapies, Salzburg, Austria; Rohde; Gimona: Paracelsus Med Univ, Celericon Therapeut GmbH, Salzburg, Austria",

year = "2019",

doi = "10.1016/j.jcyt.2018.12.006",

language = "English",

volume = "21",

pages = "581--592",

journal = "CYTOTHERAPY",

issn = "1465-3249",

publisher = "Taylor & Francis ",

number = "6",

}

TY - JOUR

T1 - Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing.

AU - Rohde, Eva

AU - Pachler, Karin

AU - Gimona, Mario

N1 - all: Paracelsus Med Univ, GMP Lab, SCI TReCS, Salz; Paracelsus Med Univ, Dept Transfus Med, Salzburg, Austria; Paracelsus Med Univ, Res Program Nanovesicular Therapies, Salzburg, Austria; Rohde; Gimona: Paracelsus Med Univ, Celericon Therapeut GmbH, Salzburg, Austria

PY - 2019

Y1 - 2019

KW - INCLUDING STEM-CELLS

KW - A METHOD

KW - EXOSOMES

KW - MICRORNAS

KW - GROWTH

KW - ANGIOGENESIS

KW - INHIBIT

KW - PROGENY

KW - EUROPE

KW - US

U2 - 10.1016/j.jcyt.2018.12.006

DO - 10.1016/j.jcyt.2018.12.006

M3 - Review article

C2 - 30979664

SN - 1465-3249

VL - 21

SP - 581

EP - 592

JO - CYTOTHERAPY

JF - CYTOTHERAPY

IS - 6

ER -